SIDRANSKY DAVID - Insider Non-Derivative Transactions at Ayala Pharmaceuticals, Inc. (ADXS) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jan 19, 2023, SIDRANSKY DAVID's relationship to Ayala Pharmaceuticals, Inc. (ADXS) is Director, and currently has 46 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ADXS insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

SIDRANSKY DAVID - Insider Non-Derivative Transactions of ADXS Common Stock

SIDRANSKY DAVID - Insider Non-Derivative Transactions at ADXS

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jan 20, 2023	Acquisition -- (Common Stock)	46	0	46